121 related articles for article (PubMed ID: 9140432)
1. Serum lactate dehydrogenase level in patients with nasopharyngeal carcinoma.
Liaw CC; Wang CH; Huang JS; Kiu MC; Chen JS; Chang HK
Acta Oncol; 1997; 36(2):159-64. PubMed ID: 9140432
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era.
Chen Z; Guo Q; Lu T; Lin S; Zong J; Zhan S; Xu L; Pan J
Med Sci Monit; 2017 Jan; 23():437-445. PubMed ID: 28120819
[TBL] [Abstract][Full Text] [Related]
3. High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma.
Wan XB; Wei L; Li H; Dong M; Lin Q; Ma XK; Huang PY; Wen JY; Li X; Chen J; Ruan DY; Lin ZX; Chen ZH; Liu Q; Wu XY; Hong MH
Eur J Cancer; 2013 Jul; 49(10):2356-64. PubMed ID: 23541571
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of dynamic serum lactate dehydrogenase assessments in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
Zhou GQ; Ren XY; Mao YP; Chen L; Sun Y; Liu LZ; Li L; Lin AH; Mai HQ; Ma J
Sci Rep; 2016 Mar; 6():22326. PubMed ID: 26928265
[TBL] [Abstract][Full Text] [Related]
5. Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
Turen S; Ozyar E; Altundag K; Gullu I; Atahan IL
Cancer Invest; 2007 Aug; 25(5):315-21. PubMed ID: 17661206
[TBL] [Abstract][Full Text] [Related]
6. Serum lactic dehydrogenase strongly predicts survival in metastatic nasopharyngeal carcinoma treated with palliative chemotherapy.
Jin Y; Ye X; Shao L; Lin BC; He CX; Zhang BB; Zhang YP
Eur J Cancer; 2013 May; 49(7):1619-26. PubMed ID: 23266049
[TBL] [Abstract][Full Text] [Related]
7. Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis.
Zhou GQ; Tang LL; Mao YP; Chen L; Li WF; Sun Y; Liu LZ; Li L; Lin AH; Ma J
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e359-65. PubMed ID: 22000748
[TBL] [Abstract][Full Text] [Related]
8. [Effect of pretreatment serum LDH and ALP levels on the prognosis of patients with nasopharyngeal carcinoma].
Zhou JY; Chen T; Li W; Ye K; Wei ZB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jul; 31(14):1069-1073. PubMed ID: 29798242
[No Abstract] [Full Text] [Related]
9. Post-treatment serum lactic dehydrogenase as a predictive indicator for distant metastasis and survival of patients with nasopharyngeal carcinoma.
Wang J; Li L; Dong BQ; Xu YJ; Zheng YD; Sun ZW; Yang Y; Chen YY; Chen XZ; Chen M
Oncotarget; 2016 May; 7(19):27458-67. PubMed ID: 27050275
[TBL] [Abstract][Full Text] [Related]
10. Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L.
Liu R; Cao J; Gao X; Zhang J; Wang L; Wang B; Guo L; Hu X; Wang Z
Tumour Biol; 2016 Oct; 37(10):14083-14088. PubMed ID: 27511116
[TBL] [Abstract][Full Text] [Related]
11. Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy.
Cheng SH; Jian JJ; Tsai SY; Chan KY; Yen LK; Chu NM; Tan TD; Tsou MH; Huang AT
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):755-62. PubMed ID: 9652835
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of pretreatment serum LDH in patients with limited disease small-cell lung carcinoma.
Stokkel MP; Van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
Int J Biol Markers; 1997; 12(4):162-7. PubMed ID: 9582606
[TBL] [Abstract][Full Text] [Related]
13. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
van Zandwijk N; Jassem E; Bonfrer JM; Mooi WJ; van Tinteren H
Semin Oncol; 1992 Feb; 19(1 Suppl 2):37-43. PubMed ID: 1329221
[TBL] [Abstract][Full Text] [Related]
14. Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.
Lee DS; Park KR; Kim SJ; Chung MJ; Lee YH; Chang JH; Kang JH; Hong SH; Kim MS; Kim YS
Tumour Biol; 2016 Jan; 37(1):619-25. PubMed ID: 26240025
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
Sagman U; Feld R; Evans WK; Warr D; Shepherd FA; Payne D; Pringle J; Yeoh J; DeBoer G; Malkin A
J Clin Oncol; 1991 Jun; 9(6):954-61. PubMed ID: 1851821
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of serum lactate dehydrogenase in osteosarcoma of the extremity: experience at Rizzoli on 1421 patients treated over the last 30 years.
Bacci G; Longhi A; Ferrari S; Briccoli A; Donati D; De Paolis M; Versari M
Tumori; 2004; 90(5):478-84. PubMed ID: 15656333
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma.
Egberts F; Kotthoff EM; Gerdes S; Egberts JH; Weichenthal M; Hauschild A
Eur J Cancer; 2012 Mar; 48(5):695-702. PubMed ID: 21917447
[TBL] [Abstract][Full Text] [Related]
18. Serum Lactate Dehydrogenase Can Be Used as a Factor for Re-Evaluating First-Relapsed Multiple Myeloma.
Liu Y; Wen L; Chen H; Chen Y; Duan W; Kang Y; Ma L; Huang X; Lu J
Acta Haematol; 2020; 143(6):559-566. PubMed ID: 32610311
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment serum LDH as additional staging parameter in small-cell lung carcinoma.
Stokkel MP; van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
Neth J Med; 1998 Feb; 52(2):65-70. PubMed ID: 9557528
[TBL] [Abstract][Full Text] [Related]
20. Serum lactate dehydrogenase (LDH) as a tumor marker in Ewing's sarcoma.
Bacci G; Avella M; McDonald D; Toni A; Orlandi M; Campanacci M
Tumori; 1988 Dec; 74(6):649-55. PubMed ID: 3232209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
